Microsatellite instability in European hepatocellular carcinoma

被引:67
作者
Salvucci, M
Lemoine, A
Saffroy, R
Azoulay, D
Lepère, B
Gaillard, S
Bismuth, H
Reynès, R
Debuire, B
机构
[1] Hop Paul Brousse, Dept Biochem, F-94804 Villejuif, France
[2] Hop Paul Brousse, Hepatobiliary Surg & Liver Transplant Res Unit, F-94804 Villejuif, France
[3] Hop Paul Brousse, Dept Pathol, F-94804 Villejuif, France
[4] Fac Med Paris Sud, CEA, CNRS, UMR 217, Fontenay Aux Roses, France
关键词
transforming growth factor (TGF beta) type II; receptor (RII) gene; cirrhosis; clinicopathological characteristics; recurrent disease; prognostic factor;
D O I
10.1038/sj.onc.1202279
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genetic instability has been detected in many types of cancers but poorly investigated in hepatocellular carcinoma (HCC). We have studied the incidence of microsatellite instability (MI) at eight highly polymorphic microsatellite markers and the poly A tract BAT26 and tested for mutations at two sites of repetitive sequence (poly-A nucleotides 709-718 and GT repeat-nucleotides 1931-1936) in the Transforming Growth Factor beta (TGF beta) type II receptor (RII) gene, in a group of 46 European HCCs and the surrounding nontumour tissue. This analysis showed that 63% of HCCs exhibit MI in at least one chromosome locus and 41% in two or more loci. No mutations of the TGF beta RII gene were found in the MI positive tumours. No correlation was found with clinicopathological characteristics of the tumours such as cirrhosis, etiology, number of nodules, Edmondson's grade and vascular invasion. However, in patients who had a rearranged D16S402 microsatellite in their tumour, the recurrent disease and the number of nodules were significantly higher than in the others (P<0.005 and P<0.02, respectively). We propose to consider D16S402 rearrangement in HCC as a prognostic factor to identify patients presenting a higher risk of recurrence.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 47 条
  • [1] The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability
    Abe, T
    Hong, OY
    Migita, T
    Kato, Y
    Kimura, M
    Shiiba, K
    Sunamura, M
    Matsuno, S
    Horii, A
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (05): : 474 - 477
  • [2] AKASHI Y, 1991, HEPATOLOGY, V14, P262, DOI 10.1002/hep.1840140210
  • [3] ARZIMANOGLOU IA, 1996, CARCINOGENESIS, V47, P1799
  • [4] LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS
    BISMUTH, H
    CHICHE, L
    ADAM, R
    CASTAING, D
    DIAMOND, T
    DENNISON, A
    [J]. ANNALS OF SURGERY, 1993, 218 (02) : 145 - 151
  • [5] Boige V, 1997, CANCER RES, V57, P1986
  • [6] P53 PROTEIN ACCUMULATION IN EUROPEAN HEPATOCELLULAR-CARCINOMA IS NOT ALWAYS DEPENDENT ON P53 GENE MUTATION
    BOURDON, JC
    DERRICO, A
    PATERLINI, P
    GRIGIONI, W
    MAY, E
    DEBUIRE, B
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : 1176 - 1182
  • [7] BRENTNALL TA, 1995, CANCER RES, V55, P4264
  • [8] Brentnall TA, 1996, CANCER RES, V56, P1237
  • [9] Chung YJ, 1996, CANCER RES, V56, P4662
  • [10] DeMarchis L, 1997, CLIN CANCER RES, V3, P241